Press Releases
November 26, 2019
Surface Oncology to Present at Evercore ISI 2nd Annual HealthCONx Conference
November 25, 2019
Surface Oncology Announces $25 Million Debt Financing from K2 HealthVentures
November 18, 2019
Surface Oncology Announces Filing of IND for CD39 Targeted Antibody Candidate, SRF617, at Inaugural R&D Day
November 12, 2019
Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2019
November 7, 2019
Surface Oncology Presents Updates at the Society for Immunotherapy of Cancer’s Annual Meeting
October 7, 2019
Surface Oncology to Host Analyst and Investor Day on November 18, 2019 in New York City
September 3, 2019
Surface Oncology to Present at the Baird 2019 Global Healthcare Conference
September 3, 2019
Ramy Ibrahim, M.D. to Join Surface Oncology Board of Directors
August 7, 2019
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2019
June 7, 2019
Surface Oncology to Participate in 40th Annual Goldman Sachs Global Healthcare Conference
Displaying 1 - 10 of 20